VYNE Therapeutics Inc (VYNE)
2.55
0.00 (0.00%)
USD |
NASDAQ |
May 31, 16:00
2.63
+0.08
(+3.14%)
After-Hours: 20:00
VYNE Therapeutics Cash from Operations (Quarterly): -7.982M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -7.982M |
| December 31, 2023 | -5.137M |
| September 30, 2023 | -5.152M |
| June 30, 2023 | -9.574M |
| May 31, 2023 | 218.46M |
| March 31, 2023 | -5.478M |
| December 31, 2022 | -4.811M |
| September 30, 2022 | -7.125M |
| June 30, 2022 | -8.225M |
| March 31, 2022 | -9.039M |
| December 31, 2021 | -10.02M |
| September 30, 2021 | -17.54M |
| June 30, 2021 | -16.26M |
| March 31, 2021 | -12.55M |
| December 31, 2020 | -25.38M |
| Date | Value |
|---|---|
| September 30, 2020 | -23.64M |
| June 30, 2020 | -35.86M |
| March 31, 2020 | -52.21M |
| December 31, 2019 | -16.41M |
| September 30, 2019 | -16.38M |
| June 30, 2019 | -14.25M |
| March 31, 2019 | -18.06M |
| December 31, 2018 | -16.62M |
| September 30, 2018 | -12.17M |
| June 30, 2018 | -12.74M |
| March 31, 2018 | -11.20M |
| December 31, 2017 | -10.16M |
| September 30, 2017 | -12.52M |
| June 30, 2017 | 0.037M |
| March 31, 2017 | -5.584M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-52.21M
Minimum
Mar 2020
218.46M
Maximum
May 2023
-4.026M
Average
-10.02M
Median
Dec 2021
Cash from Operations (Quarterly) Benchmarks
| Viking Therapeutics Inc | -6.134M |
| AN2 Therapeutics Inc | -17.59M |
| NovaBay Pharmaceuticals Inc | -1.572M |
| Palatin Technologies Inc | -8.607M |
| iBio Inc | -3.654M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -3.569M |
| Cash from Financing (Quarterly) | -0.004M |
| Free Cash Flow | -27.84M |
| Free Cash Flow Per Share (Quarterly) | -0.1875 |
| Free Cash Flow to Equity (Quarterly) | -7.982M |
| Free Cash Flow to Firm (Quarterly) | -7.982M |
| Free Cash Flow Yield | -69.07% |